Portfolio Rapha Capital Management

ControlRad™ Announces FDA Clearance and Launch of the Only Radiation Reduction Technology that Integrates into Mobile C-arms

By Kevin SlawinMay 22, 2019February 4th, 2021No Comments

Control Rad™
ControlRad™ Announces FDA Clearance and Launch of the Only Radiation Reduction Technology that Integrates into Mobile C-arms
May 22, 2019

Previous PostMarker Therapeutics to Report Updated Results from Phase 1/2 Trial with MultiTAA Therapy in Patients with Pancreatic Adenocarcinoma
Next PostPoseida Therapeutics Receives US FDA Orphan Drug Designation for P-BCMA-101 for the Treatment of Multiple Myeloma

© 2024 Ponce Therapeutics. Privacy Policy | Terms & Conditions